← Leaderboards
Amal F Khalil Kaddoumi
University Of Louisiana At Monroe
$2,022,299
Attributed
$2,289,790
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $768.3K · FY2015–25$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,289,790 · 5
By mechanism
R21$793,146 · 2
R33$768,262 · 1
R15$419,720 · 1
R61$308,662 · 1
Top collaborators
- Peter Rolf Panizzi2 shared
- Miranda Nicole Reed2 shared
Most similar at University Of Louisiana At Monroe
Same institution · by research overlap
- Khalid A El Sayed$1,685,985
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposEndothelial CellsDementiaReportingMediatingHealth Care CostsMouse ModelHigh Throughput ScreeningCerebral Amyloid AngiopathyPermeabilityIn VivoLaboratoriesVascular DiseasesIn VitroS DiseaseBlood - Brain Barrier AnatomyCerebrovascularBlood VesselsAmyloid Beta-ProteinBrainCharacteristicsAstrocytesLibrariesCerebrovascular System
Grant awards (8)
Repurposing of R-etodolac for Alzheimer's disease and related disorders$768,262
R33 · FY2025 · NS · contact PI
Repurposing of R-etodolac for Alzheimer's disease and related disorders$308,662
R61 · FY2023 · NS · contact PI
5HT3 receptors and blood-brain barrier dysfunction in ADRD$212,569
R21 · FY2023 · NS · contact PI
5HT3 receptors and blood-brain barrier dysfunction in ADRD$179,341
R21 · FY2023 · NS · contact PI
Olive-derived oleocanthal as a novel natural product molecule to restore cerebrovascular function and integrity in a CAA mouse model$181,743
R21 · FY2018 · NS · contact PI
Olive-derived oleocanthal as a novel natural product molecule to restore cerebrovascular function and integrity in a CAA mouse model$219,493
R21 · FY2017 · NS · contact PI
Targeting cerebrovascular endothelial cells as a therapeutic approach for amyloid pathogenesis$292,017
R15 · FY2015 · NS · contact PI
Targeting cerebrovascular endothelial cells as a therapeutic approach for amyloid pathogenesis$127,703
R15 · FY2015 · NS · contact PI